T Bradshaw
Overview
Explore the profile of T Bradshaw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
149
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bradshaw T, Godden D, Coyle M, Finley B, Beaumont I, Beech A
Br J Oral Maxillofac Surg
. 2021 Jul;
60(1):30-33.
PMID: 34275679
The Royal College of Surgeons of England stipulates that to hold a substantive specialty or associate specialist (SAS) grade post a person must be a minimum of 4 years post-graduation...
2.
Bradshaw T, Blakemore A, Wilson I, Fitzsimmons M, Crawford K, Mairs H
Nurse Educ Today
. 2020 Nov;
96:104626.
PMID: 33157364
Objectives: To identify and synthesise data from studies that have evaluated the outcomes of voice hearing simulation as an educational intervention with health care professionals and those in training. Design:...
3.
Maharaj A, Williams J, Bradshaw T, Guran T, Braslavsky D, Casas J, et al.
J Steroid Biochem Mol Biol
. 2020 Jul;
202:105730.
PMID: 32682944
Deficiency in Sphingosine-1-phosphate lyase (S1P lyase) is associated with a multi-systemic disorder incorporating primary adrenal insufficiency (PAI), steroid resistant nephrotic syndrome and neurological dysfunction. Accumulation of sphingolipid intermediates, as seen...
4.
Clarke L, Bradshaw T, Pemberton M, Barry S
Br Dent J
. 2019 Jan;
226(1):3.
PMID: 30631183
No abstract available.
5.
Namias M, Bradshaw T, Menezes V, Machado M, Jeraj R
Phys Med Biol
. 2018 May;
63(9):095019.
PMID: 29726406
Positron emission tomography (PET) imaging allows for measurement of activity concentrations of a given radiotracer in vivo. The quantitative capabilities of PET imaging are particularly important in the context of...
6.
Carney R, Cotter J, Firth J, Bradshaw T, Yung A
Acta Psychiatr Scand
. 2017 Feb;
136(1):5-15.
PMID: 28168698
Objective: We aimed to assess whether individuals at ultra high risk (UHR) for psychosis have higher rates of cannabis use and cannabis use disorders (CUDs) than non-UHR individuals and determine...
7.
Aust J, Bradshaw T
J Psychiatr Ment Health Nurs
. 2016 Dec;
24(1):69-83.
PMID: 27928859
Abstract: Introduction A growing number of mindfulness interventions are being used with individuals with psychosis. These therapies employ elements of acceptance and compassion in addition to mindfulness. A number of...
8.
Carney R, Yung A, Amminger G, Bradshaw T, Glozier N, Hermens D, et al.
Schizophr Res
. 2016 Sep;
181:23-29.
PMID: 27590573
Background: People with schizophrenia have high rates of substance use which contributes to co-morbidity and premature mortality. Some evidence suggests people at-risk for psychosis have high rates of substance use....
9.
Carney R, Bradshaw T, Yung A
Acta Psychiatr Scand
. 2015 Dec;
133(2):166-167.
PMID: 26637963
No abstract available.
10.
Johnson-Davis K, Juenke J, Thomas R, Bradshaw T
Ann Clin Lab Sci
. 2015 Feb;
45(1):27-31.
PMID: 25696007
Unlabelled: Everolimus is an immunosuppressant drug that was approved for prophylactic use in the United States to prevent organ rejection in adult kidney and liver transplant recipients. Therapeutic drug management...